ε2ε3 carriers differed from ε3ε3 in having lower risk of IHD, lower SBP, pulse pressure and plasma apoB, and nominally lower HbA1c, but similar DBP and risk of diabetes (Figs. 1B and 2B). The gene discussed is APOB; the disease is myocardial ischemia.